Skip to main content

FDA Calls for Better Accuracy of Pulse Oximeters in People of Color

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 8, 2025.

By India Edwards HealthDay Reporter

TUESDAY, Jan. 7, 2025 -- Pulse oximeters -- those tiny devices that measure blood oxygen levels with a quick clip to your finger -- may soon get a major upgrade to ensure they work just as well for people of all skin tones.

The U.S. Food and Drug Administration (FDA) released draft guidelines on Jan. 6 proposing that manufacturers conduct larger, more inclusive studies to ensure these devices, which became essential during COVID-19, work for people with darker skin.

Among the key changes, the new recommendations call for:

The proposal applies only to professional pulse oximeters used in medical settings, such as hospitals and clinics. Over-the-counter oximeters, often marketed as "general wellness" devices, are not affected.

The FDA's recommendations come after studies, including one from 2021, found that pulse oximeters often overestimate oxygen levels in Black patients, potentially delaying treatment and increasing health risks, a news release states.

Existing devices already on the market will not need to meet these new standards unless manufacturers request updates or modifications.

The FDA will accept public comments on the draft proposal for 60 days before finalizing the guidelines.

Sources

  • The U.S. Food and Drug Administration (FDA), federal proposal draft, Jan. 6
  • AP News

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted January 2025

Read this next

FDA Authorizes First AI Platform for Breast Cancer Prediction

FRIDAY, June 6, 2025 -- The U.S. Food and Drug Administration has granted de novo authorization to CLAIRITY BREAST, a first-in-class, image-based platform that can help predict a...

4 States Ask FDA to Lift Rules on Abortion Pill Mifepristone

FRIDAY, June 6, 2025 — Attorneys general from four states are asking the U.S. Food and Drug Administration (FDA) to lift restrictions on mifepristone, a pill used in...

Long-Lasting HIV Prevention Shot Headed Toward Approval

FRIDAY, June 6, 2025 — A new injection to prevent HIV is expected to be approved by the U.S. Food and Drug Administration (FDA) later this month. If approved, the shot...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.